miR-378a-3p sensitizes ovarian cancer cells to cisplatin through targeting MAPK1/GRB2
Xu, Zhi-hong, Yao, Tie-zhu, Liu, WeiVolume:
107
Language:
english
Journal:
Biomedicine & Pharmacotherapy
DOI:
10.1016/j.biopha.2018.08.132
Date:
November, 2018
File:
PDF, 2.54 MB
english, 2018